These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 31165837)
1. Sinapine reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota. Li Y; Li J; Su Q; Liu Y Food Funct; 2019 Jun; 10(6):3637-3649. PubMed ID: 31165837 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642 [TBL] [Abstract][Full Text] [Related]
3. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats. Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414 [TBL] [Abstract][Full Text] [Related]
4. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis. Wang P; Wang J; Li D; Ke W; Chen F; Hu X J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250 [TBL] [Abstract][Full Text] [Related]
5. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats. Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797 [TBL] [Abstract][Full Text] [Related]
6. Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis. Vitaglione P; Mazzone G; Lembo V; D'Argenio G; Rossi A; Guido M; Savoia M; Salomone F; Mennella I; De Filippis F; Ercolini D; Caporaso N; Morisco F J Nutr Sci; 2019; 8():e15. PubMed ID: 31037218 [TBL] [Abstract][Full Text] [Related]
7. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier. Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981 [TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis. Chiu CC; Ching YH; Li YP; Liu JY; Huang YT; Huang YW; Yang SS; Huang WC; Chuang HL Nutrients; 2017 Nov; 9(11):. PubMed ID: 29113135 [TBL] [Abstract][Full Text] [Related]
9. Red pitaya betacyanins protects from diet-induced obesity, liver steatosis and insulin resistance in association with modulation of gut microbiota in mice. Song H; Chu Q; Yan F; Yang Y; Han W; Zheng X J Gastroenterol Hepatol; 2016 Aug; 31(8):1462-9. PubMed ID: 26699443 [TBL] [Abstract][Full Text] [Related]
10. Supplementation of Inulin with Various Degree of Polymerization Ameliorates Liver Injury and Gut Microbiota Dysbiosis in High Fat-Fed Obese Mice. Du H; Zhao A; Wang Q; Yang X; Ren D J Agric Food Chem; 2020 Jan; 68(3):779-787. PubMed ID: 31894986 [TBL] [Abstract][Full Text] [Related]
11. Functional Interactions between Gut Microbiota Transplantation, Quercetin, and High-Fat Diet Determine Non-Alcoholic Fatty Liver Disease Development in Germ-Free Mice. Porras D; Nistal E; Martínez-Flórez S; Olcoz JL; Jover R; Jorquera F; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S Mol Nutr Food Res; 2019 Apr; 63(8):e1800930. PubMed ID: 30680920 [TBL] [Abstract][Full Text] [Related]
12. α-Lactalbumin peptide Asp-Gln-Trp alleviates hepatic insulin resistance and modulates gut microbiota dysbiosis in high-fat diet-induced NAFLD mice. Chen H; Sun Y; Zhao H; Qi X; Cui H; Li Q; Ma Y Food Funct; 2022 Oct; 13(19):9878-9892. PubMed ID: 36052713 [TBL] [Abstract][Full Text] [Related]
13. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. Wang W; Zhao J; Gui W; Sun D; Dai H; Xiao L; Chu H; Du F; Zhu Q; Schnabl B; Huang K; Yang L; Hou X Br J Pharmacol; 2018 Feb; 175(3):469-484. PubMed ID: 29139555 [TBL] [Abstract][Full Text] [Related]
14. Housing condition-associated changes in gut microbiota further affect the host response to diet-induced nonalcoholic fatty liver. Chen YH; Wang YC; Chiu CC; Lee YP; Hung SW; Huang CC; Chiu CF; Chen TH; Huang WC; Chuang HL J Nutr Biochem; 2020 May; 79():108362. PubMed ID: 32163832 [TBL] [Abstract][Full Text] [Related]
15. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice. de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG Front Immunol; 2019; 10():2926. PubMed ID: 31998283 [TBL] [Abstract][Full Text] [Related]
16. Huang Y; Cao J; Zhu M; Wang Z; Jin Z; Xiong Z Microbiol Spectr; 2024 Apr; 12(4):e0339323. PubMed ID: 38411057 [TBL] [Abstract][Full Text] [Related]
17. Molecular adaptations underlying the beneficial effects of hydroxytyrosol in the pathogenic alterations induced by a high-fat diet in mouse liver: PPAR-α and Nrf2 activation, and NF-κB down-regulation. Valenzuela R; Illesca P; Echeverría F; Espinosa A; Rincón-Cervera MÁ; Ortiz M; Hernandez-Rodas MC; Valenzuela A; Videla LA Food Funct; 2017 Apr; 8(4):1526-1537. PubMed ID: 28386616 [TBL] [Abstract][Full Text] [Related]
18. The probiotic effects of AB23A on high-fat-diet-induced non-alcoholic fatty liver disease in mice may be associated with suppressing the serum levels of lipopolysaccharides and branched-chain amino acids. Xia F; Xiang S; Chen Z; Song L; Li Y; Liao Z; Ge B; Zhou B Arch Biochem Biophys; 2021 Dec; 714():109080. PubMed ID: 34742934 [TBL] [Abstract][Full Text] [Related]
19. Propionate alleviates high-fat diet-induced lipid dysmetabolism by modulating gut microbiota in mice. Song B; Zhong YZ; Zheng CB; Li FN; Duan YH; Deng JP J Appl Microbiol; 2019 Nov; 127(5):1546-1555. PubMed ID: 31325215 [TBL] [Abstract][Full Text] [Related]
20. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse. Lee JE; Lee SM; Jung J Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]